ID

21498

Beschreibung

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Concomitant Medications Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Stichworte

Versionen (1)
  1. 25.04.17 25.04.17 -
Hochgeladen am

25. April 2017

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

  • Neueste
  • Älteste
  • Beliebt
  • Neueste
    • Neueste
    • Älteste
    • Beliebt

Keine Kommentare

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Genetic Screening For HLA-B*5701 in Patients with HIV Concomitant Medications NCT00340080

Englisch

Genetic Screening For HLA-B*5701 Concomitant Medications NCT00340080

1 Formulare  
Concomitant Medications
Beschreibung

Concomitant Medications

Alias
UMLS CUI-1
C2347852
Subject Identifier
Beschreibung

Subject Identifier

Datentyp

text

Alias
UMLS CUI [1]
C2348585
Were any concomitant medications taken by the subject at screening or during the study?
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible.

Datentyp

text

Alias
UMLS CUI [1]
C2347852
Drug Name
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible.

Datentyp

text

Alias
UMLS CUI [1,1]
C2360065
UMLS CUI [1,2]
C2347852
Start Date
Beschreibung

Start Date

Datentyp

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C2347852
Taken Prior to Study?
Beschreibung

Taken Prior to Study

Datentyp

text

Alias
UMLS CUI [1,1]
C2826667
UMLS CUI [1,2]
C2347852
Stop Date
Beschreibung

Stop Date

Datentyp

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C2347852
Ongoing Medication?
Beschreibung

Ongoing Medication

Datentyp

text

Alias
UMLS CUI [1]
C2826666
Concomitant Antiretroviral Therapy
Beschreibung

Concomitant Antiretroviral Therapy

Alias
UMLS CUI-1
C1963724
UMLS CUI-2
C2347852
Subject Identifier
Beschreibung

Subject Identifier

Datentyp

text

Alias
UMLS CUI [1]
C2348585
Is this subject receiving antiretroviral therapy (ART) other than the ABC-Containing product(s) during the study?
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible.

Datentyp

text

Alias
UMLS CUI [1]
C1963724
Drug Name
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible.

Datentyp

text

Alias
UMLS CUI [1,1]
C2360065
UMLS CUI [1,2]
C1963724
Unit Dose
Beschreibung

If Yes, record each medication on a separate line using Trade Names where possible

Datentyp

text

Alias
UMLS CUI [1,1]
C0869039
UMLS CUI [1,2]
C1963724
Unit
Beschreibung

Unit

Datentyp

text

Alias
UMLS CUI [1,1]
C1519795
UMLS CUI [1,2]
C1963724
Frequency
Beschreibung

Frequency

Datentyp

text

Alias
UMLS CUI [1,1]
C3476109
UMLS CUI [1,2]
C1963724
Start Date
Beschreibung

Start Date

Datentyp

date

Alias
UMLS CUI [1,1]
C0808070
UMLS CUI [1,2]
C1963724
Stop Date
Beschreibung

Stop Date

Datentyp

date

Alias
UMLS CUI [1,1]
C0806020
UMLS CUI [1,2]
C1963724
Ongoing Medication?
Beschreibung

Ongoing Medication

Datentyp

text

Alias
UMLS CUI [1,1]
C2826666
UMLS CUI [1,2]
C1963724
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Genetic Screening For HLA-B*5701 Concomitant Medications NCT00340080

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Concomitant Medications
C2347852 (UMLS CUI-1)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Were any concomitant medications taken by the subject at screening or during the study?
text
C2347852 (UMLS CUI [1])
antiretroviral therapy
Code List
Were any concomitant medications taken by the subject at screening or during the study?
CL Item
Yes (Y)
CL Item
No (N)
Drug Name
Item
Drug Name
text
C2360065 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item
Taken Prior to Study?
text
C2826667 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
antiretroviral therapy
Code List
Taken Prior to Study?
CL Item
Yes (Y)
CL Item
No (N)
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C2347852 (UMLS CUI [1,2])
Item
Ongoing Medication?
text
C2826666 (UMLS CUI [1])
antiretroviral therapy
Code List
Ongoing Medication?
CL Item
Yes (Y)
CL Item
No (N)
Item Group
Concomitant Antiretroviral Therapy
C1963724 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Is this subject receiving antiretroviral therapy (ART) other than the ABC-Containing product(s) during the study?
text
C1963724 (UMLS CUI [1])
antiretroviral therapy
Code List
Is this subject receiving antiretroviral therapy (ART) other than the ABC-Containing product(s) during the study?
CL Item
Yes (Y)
CL Item
No (N)
Drug Name
Item
Drug Name
text
C2360065 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Unit Dose
Item
Unit Dose
text
C0869039 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Item
Unit
text
C1519795 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Unit
Code List
Unit
CL Item
Tablet  (TAB)
CL Item
Microlitre  (MCL)
CL Item
Millilitre  (ML)
CL Item
Litre  (L)
CL Item
Microgram  (MCG)
CL Item
Milligram  (MG)
CL Item
Gram (G)
Item
Frequency
text
C3476109 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Frequency
Code List
Frequency
CL Item
1 x Daily (OD)
CL Item
2 x Daily (BID)
CL Item
3 x Daily (TID)
CL Item
4 x Daily  (QID)
CL Item
As required (PRN)
Start Date
Item
Start Date
date
C0808070 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Stop Date
Item
Stop Date
date
C0806020 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
Item
Ongoing Medication?
text
C2826666 (UMLS CUI [1,1])
C1963724 (UMLS CUI [1,2])
antiretroviral therapy
Code List
Ongoing Medication?
CL Item
Yes (Y)
CL Item
No (N)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video